Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

LncRNA HIF1A-AS1 Promotes Gemcitabine Resistance of Pancreatic Cancer by Enhancing Glycolysis through Modulating the AKT/YB1/HIF1α Pathway
Fengyu Xu, Mengqi Huang, Qingyong Chen, et al.
Cancer Research (2021) Vol. 81, Iss. 22, pp. 5678-5691
Open Access | Times Cited: 54

Showing 1-25 of 54 citing articles:

Crosstalk among m6A RNA methylation, hypoxia and metabolic reprogramming in TME: from immunosuppressive microenvironment to clinical application
Fusheng Zhang, Haiyang Liu, Meiqi Duan, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 58
Molecular and metabolic regulation of immunosuppression in metastatic pancreatic ductal adenocarcinoma
Shailendra K. Gautam, Surinder K. Batra, Maneesh Jain
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 35
LncRNA FTO-IT1 promotes glycolysis and progression of hepatocellular carcinoma through modulating FTO-mediated N6-methyladenosine modification on GLUT1 and PKM2
Fan Wang, Yuhang Hu, Hongda Wang, et al.
Journal of Experimental & Clinical Cancer Research (2023) Vol. 42, Iss. 1
Open Access | Times Cited: 23
m6A eraser FTO impairs gemcitabine resistance in pancreatic cancer through influencing NEDD4 mRNA stability by regulating the PTEN/PI3K/AKT pathway
Kai Lin, Endi Zhou, Ting Shi, et al.
Journal of Experimental & Clinical Cancer Research (2023) Vol. 42, Iss. 1
Open Access | Times Cited: 21
PRMT1 promotes pancreatic cancer development and resistance to chemotherapy
Bomin Ku, David Eisenbarth, Seonguk Baek, et al.
Cell Reports Medicine (2024) Vol. 5, Iss. 3, pp. 101461-101461
Open Access | Times Cited: 11
METTL16 suppressed the proliferation and cisplatin-chemoresistance of bladder cancer by degrading PMEPA1 mRNA in a m6A manner through autophagy pathway
Hao Yu, Juntao Zhuang, Zijian Zhou, et al.
International Journal of Biological Sciences (2024) Vol. 20, Iss. 4, pp. 1471-1491
Open Access | Times Cited: 10
Y-Box Binding Protein 1: Unraveling the Multifaceted Role in Cancer Development and Therapeutic Potential
Ngoc Thi Minh Dinh, Tuan Minh Nguyen, Mi Kyung Park, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 2, pp. 717-717
Open Access | Times Cited: 9
Cellular senescence and metabolic reprogramming: Unraveling the intricate crosstalk in the immunosuppressive tumor microenvironment
Fusheng Zhang, Junchen Guo, Shengmiao Yu, et al.
Cancer Communications (2024) Vol. 44, Iss. 9, pp. 929-966
Open Access | Times Cited: 8
The GFPT2-O-GlcNAcylation-YBX1 axis promotes IL-18 secretion to regulate the tumor immune microenvironment in pancreatic cancer
Huiru Zhang, Tianjiao Li, Xianjun Yu, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 4
Open Access | Times Cited: 7
GEnDDn: An lncRNA–Disease Association Identification Framework Based on Dual-Net Neural Architecture and Deep Neural Network
Lihong Peng, Mengnan Ren, Liangliang Huang, et al.
Interdisciplinary Sciences Computational Life Sciences (2024) Vol. 16, Iss. 2, pp. 418-438
Closed Access | Times Cited: 7
YB-1 as an Oncoprotein: Functions, Regulation, Post-Translational Modifications, and Targeted Therapy
Qiyan Yin, Min Zheng, Qianmei Luo, et al.
Cells (2022) Vol. 11, Iss. 7, pp. 1217-1217
Open Access | Times Cited: 34
LINC00941 promotes pancreatic cancer malignancy by interacting with ANXA2 and suppressing NEDD4L-mediated degradation of ANXA2
Jie Wang, Zhiwei He, Xinyuan Liu, et al.
Cell Death and Disease (2022) Vol. 13, Iss. 8
Open Access | Times Cited: 32
Glycolysis in the progression of pancreatic cancer.
Xinyao Chang, Xingchen Liu, Haoze Wang, et al.
PubMed (2022) Vol. 12, Iss. 2, pp. 861-872
Closed Access | Times Cited: 28
The role of metabolic reprogramming in pancreatic cancer chemoresistance
Chang Liu, Changfeng Li, Yuanda Liu
Frontiers in Pharmacology (2023) Vol. 13
Open Access | Times Cited: 20
MicroRNAs and long non-coding RNAs in pancreatic cancer: From epigenetics to potential clinical applications
Luis Alberto Bravo-Vázquez, Natalia Frías-Reid, Ana Gabriela Ramos-Delgado, et al.
Translational Oncology (2022) Vol. 27, pp. 101579-101579
Open Access | Times Cited: 22
CDKN3 Overcomes Bladder Cancer Cisplatin Resistance via LDHA-Dependent Glycolysis Reprogramming
Mengxuan Li, Nan Che, Yu Jin, et al.
OncoTargets and Therapy (2022) Vol. Volume 15, pp. 299-311
Open Access | Times Cited: 20
Extracellular Vesicle-Loaded Oncogenic lncRNA NEAT1 from Adipose-Derived Mesenchymal Stem Cells Confers Gemcitabine Resistance in Pancreatic Cancer via miR-491-5p/Snail/SOCS3 Axis
Rongxiang Wu, Zhan Su, Zhao Le, et al.
Stem Cells International (2023) Vol. 2023, pp. 1-21
Open Access | Times Cited: 11
Targeting Neutrophil Extracellular Traps: A Novel Antitumor Strategy
Hao Zuo, Mengjie Yang, Qian Ji, et al.
Journal of Immunology Research (2023) Vol. 2023, pp. 1-11
Open Access | Times Cited: 11
Hypoxia-Inducible Factor-Dependent and Independent Mechanisms Underlying Chemoresistance of Hypoxic Cancer Cells
Peter Wai Tik Lee, Lina Rochelle Koseki, Takao Haitani, et al.
Cancers (2024) Vol. 16, Iss. 9, pp. 1729-1729
Open Access | Times Cited: 3
Hypoxia-elicited Exosomes Promote the Chemoresistance of Pancreatic Cancer Cells by Transferring LncROR via Hippo Signaling
Huizhi Wang, Jingyu Min, Chunhui Xu, et al.
Journal of Cancer (2023) Vol. 14, Iss. 6, pp. 1075-1087
Open Access | Times Cited: 9
Long non-coding RNA KCND1 protects hearts from hypertrophy by targeting YBX1
Rui Yang, Liangliang Li, Yumeng Hou, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 5
Open Access | Times Cited: 8
Deciphering the Role of Exosomal Non-Coding RNA (ncRNA) in Drug Resistance of Gastrointestinal Tumors; an Updated Review
Nafiseh Tashakori, Maryam Armanfar, A H Ziaee Mashhadi, et al.
Cell Biochemistry and Biophysics (2024) Vol. 82, Iss. 2, pp. 609-621
Closed Access | Times Cited: 2
Exploring Unique Extracellular Vesicles Associated Signatures: Prognostic Insights, Immune Microenvironment Dynamics, and Therapeutic Responses in Pancreatic Adenocarcinoma
Kai Nan, Ming Zhang, Zilong Geng, et al.
Mediators of Inflammation (2024) Vol. 2024, Iss. 1
Open Access | Times Cited: 2
Role of the long non-coding RNAs in regulation of Gemcitabine response in tumor cells
Amirhosein Maharati, Yalda Samsami, Hanieh Latifi, et al.
Cancer Cell International (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 7
A prognostic model based on tumor microenvironment-related lncRNAs predicts therapy response in pancreatic cancer
Jianzhong Lu, Jinhua Tan, Xiaoqing Yu
Functional & Integrative Genomics (2023) Vol. 23, Iss. 1
Closed Access | Times Cited: 6
Page 1 - Next Page

Scroll to top